https://secureservercdn.net/22.214.171.124/5x0.84a.myftpupload.com/wp-content/uploads/2019/06/VaccineEnterprise_withtext_980x228.png00Roger Tatoudhttps://secureservercdn.net/126.96.36.199/5x0.84a.myftpupload.com/wp-content/uploads/2019/06/VaccineEnterprise_withtext_980x228.pngRoger Tatoud2019-08-27 16:42:322019-08-27 16:44:21GHVE feedback on the European Commission inception impact assessment 27AUG19
Established in 2003, the Global HIV Vaccine Enterprise (the Enterprise) became a programme of IAS – the International AIDS Society – in 2018. The Enterprise unites stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of – and future access to – an HIV vaccine.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: